Immunis, Inc. has formally signed a clinical trial agreement with California Institute of Regenerative Medicine (CIRM) Alpha Stem Cell Clinics Network to initiate STEM-MYO Phase I/IIa clinical trials.
[Immunis, Inc. (Business Wire)]
Home Newsletters Cell Therapy News Immunis Signs Clinical Trial Agreement with CIRM Alpha Stem Cell Clinics
